Former FDA Director
Direct oversight of national enforcement and federal investigations from a central authority.
Global Expert
Elite guidance for multi-national organizations navigating intricate international quality mandates.
28+ Years Experience
Unrivaled seniority in pharma, device, and biotech remediation for high-stakes stakeholders.
Former FDA Investigations Chief
Bridging Federal Oversight and Global Strategy
Ricki A. Chase is a former FDA Director of Investigations and elite compliance strategist with 28+ years of leadership across pharma, device, biotech, and combo product sectors.
She transforms complex regulatory hurdles into sustainable business advantages—architecting risk-based quality systems that meet the highest FDA and international standards.
Ricki leverages her background in federal enforcement to provide C-suite leaders with the decisive counsel needed for high-impact remediation and inspection success.
PHARMA
DEVICE
COMBO
BIOTECH
BIMO
Executive Regulatory Strategy
Translating FDA complexity into decisive competitive advantages for industry leaders.